STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners
Oregon Health and Science University
640 participants
Jun 23, 2025
INTERVENTIONAL
Conditions
Summary
The purpose of this nationwide study is to test STELLA-FTD (Support via Telehealth: Living and Learning with Advancing Alzheimer's Disease)-FTD, an intervention to specifically address the needs of family Care Partners of persons with frontotemporal degeneration (FTD). STELLA-FTD is a multicomponent videoconference-based intervention designed to facilitate effective use of community and peer resources to foster effective management of behavioral and psychological symptoms of dementia. The study is recruiting families from across the United States.
Eligibility
Inclusion Criteria11
- Adult caring for family member with FTD.
- Provides 4 or more hours of care/week. Does not have to reside with.
- Identifies at least 2 moderately upsetting behaviors in the person with FTD.
- Speaks and understands English to be able to participate in intervention.
- Owns a telephone (smartphone, cell phone or landline).
- Has email and mailing address to receive computer, study materials and surveys.
- Provides informed consent to participate in the research.
- Lives in the US
- Diagnosis of FTD
- Family member of a Care Partner (this can be a relative, spouse, or close kin that is considered family).
- Lives in US
Exclusion Criteria7
- No Frontotemporal Degeneration diagnosis.
- Unable to leave Care Partner during STELLA-FTD sessions.
- Enrolled in hospice.
- Unable to find activity for Care Recipient during STELLA-FTD sessions to allow Care Partner to work privately with Guide and other Care Partners.
- Hearing and/or vision problems severe enough to prevent participation.
- Refuses to be video-recorded during STELLA-FTD sessions.
- Unwilling or unable to adequately follow study instructions and participate in study procedures.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants receive information about FTD and support via weekly group video-conference-based meetings.
The test group receives a information and support, but with a focus that is different from the Control Group
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06613204